Finance

Beta
Lists
600976:SHA
Jianmin Pharmaceutical Group Co Ltd
CN¥26.50
+0.19%
(+0.050) 1D
Jun 15, 3:00:06 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600976...
Open
CN¥26.37
High
CN¥26.85
Low
CN¥26.25
Mkt. cap
4.06B
Avg. vol.
1.67M
Volume
2.00M
Dividend
3.40%
Quarterly dividend
CN¥0.22
Ex-dividend date
Apr 28, 2026
P/E ratio
11.86
52-wk high
CN¥43.72
52-wk low
CN¥25.91
EPS
CN¥2.24
Shares outstanding
153.40M
No. of employees
2K
Open
CN¥26.37
High
CN¥26.85
Low
CN¥26.25
Mkt. cap
4.06B
Avg. vol.
1.67M
Volume
2.00M
Dividend
3.40%
Quarterly dividend
CN¥0.22
Ex-dividend date
Apr 28, 2026
P/E ratio
11.86
52-wk high
CN¥43.72
52-wk low
CN¥25.91
EPS
CN¥2.24
Shares outstanding
153.40M
No. of employees
2K
News stories
From sources across the web
About Jianmin Pharmaceutical Group Co Ltd
CEO-
Employees2.26K
Founded1637
Headquarters-
SectorPharmaceutical industry
Websitewhjm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
912.51M
747.33M
817.97M
873.07M
Cost of goods sold
354.91M
308.14M
368.28M
303.81M
Cost of revenue
354.91M
308.14M
368.28M
303.81M
Research and development expenses
31.96M
25.35M
20.36M
21.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
454.86M
380.38M
358.68M
466.52M
Operating expense
488.79M
397.96M
414.67M
495.06M
Total operating expenses
843.70M
706.10M
782.95M
798.87M
Operating income
68.81M
41.23M
35.03M
74.20M
Other non operating income
-308.25K
1.12M
4.29M
-479.82K
EBT including unusual items
114.44M
66.53M
85.30M
97.54M
EBT excluding unusual items
95.13M
75.14M
51.48M
85.01M
Income tax expense
3.11M
298.91K
8.69M
9.23M
Effective tax rate
2.72%
0.45%
10.18%
9.46%
Other operating expenses
1.97M
-7.77M
18.05M
7.27M
Net income
110.45M
65.11M
74.10M
87.73M
Net profit margin
12.10%
8.71%
9.06%
10.05%
Earnings per share
-
-
-
-
Interest and investment income
28.72M
35.73M
17.09M
13.91M
Interest expense
-2.09M
-2.94M
-4.93M
-2.62M
Net interest expenses
26.63M
32.79M
12.16M
11.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
77.33M
49.63M
44.41M
83.59M
Gain or loss from assets sale
342.53K
-342.53K
154.53K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer